logo

SMG

The Scotts Miracle-Gro·NYSE
--
--(--)
--
--(--)
5.31 / 10
Netural

Fundamental health is average (5.3/10). Strengths include PB‑ROE and Net‑income‑Revenue ratios, both scoring high. Weak points are cash growth (Cash‑UP) and revenue relative to market value (Revenue‑MV). Overall fund‑based score is 5.31, indicating modest but not strong fundamentals.

Fundamental(5.31)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value-0.03
Score1/3
Weight8.63%
1M Return2.98%
Net cash flow from operating activities per share (YoY growth rate %)
Value-45.05
Score1/3
Weight6.50%
1M Return2.27%
Profit-MV
Value0.66
Score2/3
Weight11.43%
1M Return3.64%
Net income-Revenue
Value-0.04
Score2/3
Weight9.50%
1M Return3.37%
PB-ROE
Value0.04
Score3/3
Weight19.78%
1M Return6.04%
Cash-UP
Value-1.03
Score1/3
Weight-0.57%
1M Return-0.24%
Long-term debt to working capital ratio (%)
Value11.76
Score1/3
Weight5.87%
1M Return2.09%
Interest coverage ratio (EBIT / Interest expense) (%)
Value2.72
Score3/3
Weight19.67%
1M Return6.47%
Equity multiplier (DuPont analysis %)
Value-7.50
Score0/3
Weight-1.55%
1M Return-0.63%
Current ratio
Value1.27
Score3/3
Weight20.74%
1M Return7.19%
Is SMG undervalued or overvalued?
  • SMG scores 5.31/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 2.64% net margin, 39.35 P/E ratio, -7.05 P/B ratio, and 492.50% earnings growth, these metrics solidify its Netural investment rating.